Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych MEQs / SAQsFoundations — psychological and neuropsychological testing

Psych MEQs / SAQs · Foundations — psychological and neuropsychological testing

Design a cognitive assessment pathway for complex presentations (MEQ)

FRANZCP-style MEQ on screens vs batteries, MoCA caveats, NP referral, schizophrenia cognition evidence, and communication.

20 marks20 min
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar. A 68-year-old with late-onset psychotic depression has residual low mood, family report of forgetfulness, and MoCA 22/30 after partial response to an antidepressant. Separately, a 29-year-old with schizophrenia is being considered for a vocational rehabilitation programme. (i) Distinguish bedside cognitive screening from formal neuropsychological assessment and from symptom rating scales. (ii) Interpret the MoCA result with carefully cited caveats and list immediate confounds to exclude (including delirium). (iii) State when you would refer for formal NP and what the referral question should specify. (iv) For the schizophrenia patient, name evidence-based cognitive assessment approaches (e.g. MCCB/BACS) and why cognition matters for function (Green). (v) Outline how you would explain testing and results to each patient in plain language. (20 marks)

Model answer

Reveal model answer

(i) Distinctions. Bedside screens (MoCA/MMSE/FAB) are brief triage tools. Formal neuropsychological assessment is hypothesis-driven multi-domain testing with norms, validity indices, and functional interpretation by trained examiners. Symptom rating scales (e.g. PHQ-9, PANSS) quantify psychiatric symptom constructs and do not replace domain-level cognitive profiling. Diagnosis and capacity remain clinical judgements informed by — not replaced by — scores.[1][4][7]

(ii) MoCA 22 interpretation. MoCA was validated as an MCI-oriented brief screen; scores around/below the commonly taught cut near 26 raise concern for cognitive impairment needing full assessment, but Carson et al. caution against universal cut-offs. A score of 22 is not a dementia diagnosis. Exclude delirium (CAM features: acute onset/fluctuation, inattention), depression effects, medications, sensory limits, language/education mismatch, sleep, substances, and suboptimal effort. Complete collateral, function (IADLs), and basic organic work-up as indicated.[1][2][3]

(iii) Formal NP referral. Refer when diagnostic uncertainty remains, progressive or atypical pattern, high-stakes functional decisions, or need for domain profile beyond screening. Specify: referral question (e.g. amnestic vs dysexecutive pattern; contribution of mood vs neurodegenerative disease), relevant history, medications, language, education, sensory issues, and request for validity assessment if inconsistency suspected.[7]

(iv) Schizophrenia cognition. Use MCCB (consensus trial battery with reliability/validity data) or BACS as a briefer validated alternative. Green’s synthesis shows neurocognitive deficits constrain community function more tightly than residual positive symptoms alone — justifying cognitive characterisation for vocational planning and remediation, not only antipsychotic optimisation.[4][5][6]

(v) Communication. Older adult: explain MoCA as a check of thinking skills, not a pass/fail intelligence test; share that low scores mean we look carefully for treatable causes and may arrange specialist testing; emphasise partnership. Schizophrenia patient: frame cognitive testing as identifying strengths and difficulties for work/rehab supports; normalise that many people with schizophrenia have thinking-speed or memory challenges independent of “being crazy”; offer written summary and follow-up.[1][4][6]

Common errors

Calling MoCA diagnostic of Alzheimer disease; skipping delirium; equating IQ with capacity; ignoring education/language; knowing MCCB name without Green functional rationale; jargon-heavy feedback without practical next steps.[1][2][3][6]

References

  1. [1]Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc, 2005.PMID 15817019
  2. [2]Carson N, Leach L, Murphy KJ A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores Int J Geriatr Psychiatry, 2018.PMID 28731508
  3. [3]Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium Ann Intern Med, 1990.PMID 2240918
  4. [4]Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity Am J Psychiatry, 2008.PMID 18172019
  5. [5]Keefe RS, Goldberg TE, Harvey PD, et al. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery Schizophr Res, 2004.PMID 15099610
  6. [6]Green MF What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry, 1996.PMID 8610818
  7. [7]Sachdev PS, Blacker D, Blazer DG, et al. Classifying neurocognitive disorders: the DSM-5 approach Nat Rev Neurol, 2014.PMID 25266297